Medication info
Bastatin Tablets 20 mg (Atorvastatin Calcium Trihydrate)

Bastatin Tablets 20 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›21.7mg / 1 tablet
Manufacturer / importer
IYON Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201306069 · Approved 2013.03.07 · Insurance code 658602780

Summary

Main use
Improvement of hyperlipidemia (such as familial hypercholesterolemia); prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or greater is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goals for each patient. Dose adjustments should be made at intervals of 4 weeks or longer.

Ingredients

Manufacturer
IYON Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (such as familial hypercholesterolemia); prevention of cardiovascular disease

  • Myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • increased serum triglycerides
  • homozygous familial hypercholesterolemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases. It is particularly effective in reducing the risk of myocardial infarction and stroke in the elderly, smokers, patients with hypertension, and those with a family history. Additionally, it reduces the risk of myocardial infarction and stroke in patients with type 2 diabetes and helps prevent heart failure and angina. In hyperlipidemia patients, it lowers total cholesterol and LDL-cholesterol levels while increasing HDL-cholesterol levels to improve overall lipid profile. It is also used in conjunction with dietary management for familial hypercholesterolemia in young children to help manage cholesterol levels. This medication is utilized to manage and improve various cardiovascular risk factors.

How to take

Adult dose

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or greater is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goals for each patient. Dose adjustments should be made at intervals of 4 weeks or longer.

Precautions

This medication may cause unusual symptoms in the muscles, so if muscle pain or weakness worsens, or if creatine kinase levels rise significantly, it must be discontinued. Patients at high risk for severe myopathy or rhabdomyolysis may need to temporarily stop taking the medication. This medication can impact liver function, so patients with liver disease or elevated liver enzyme levels should not take it, and must undergo regular liver function tests while on it. Pregnant or potentially pregnant women, and nursing mothers should not take this medication. It should not be administered to children under 10 years of age, nor to patients with certain genetic lactase deficiency. Alcoholics or patients with a history of liver disease, elderly patients, and those with reduced kidney function should use this medication cautiously and be carefully monitored for muscle-related side effects. Furthermore, this medication may interact with various drugs, so if other medications are being taken, one must consult a doctor or pharmacist. Caution is especially necessary when taken with CYP3A4 inhibitors or certain antibiotics and antivirals. If symptoms like muscle pain, weakness, or fever occur during treatment, healthcare professionals must be notified immediately. During treatment, appropriate contraception should be used, and upon confirmation of pregnancy, the medication must be discontinued immediately. Children, the elderly, and patients with reduced kidney or liver function should take special care while using this medication. In case of overdose, there is no specific antidote, and treatment must be administered according to symptoms, along with liver function and muscle-related testing. This medication should be stored out of the reach of children and kept in the original container to maintain quality.

Side effects

  • Apathy
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 171 more
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngalgia
  • laryngitis
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • dysesthesia
  • sensory loss
  • dysgeusia
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • rupture-related complications
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • dermatitis
  • pruritus
  • hair loss
  • vascular edema
  • angioedema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • positive leukocytes in urine
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test values
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric-duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • dysphoria
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • dysesthesia
  • dizziness
  • phototoxic reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • anxiety disorders
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesis
  • depression
  • tension headache
  • myositis
  • muscle disease
  • arthritis
  • bursitis
  • synovitis
  • myasthenia gravis
  • contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequency of urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discolored urine
  • hypoglycemia
  • increased appetite
  • vasomotor edema
  • chest pain
  • angina
  • facial swelling
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • retinal hemorrhage
  • hearing loss
  • glaucoma
  • abnormal taste
  • loss of taste
  • taste distortion
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture and should ideally be kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.